How the immune system responds to bacterial infections over time
The temporal dynamics of translation efficiency during an innate immune response
This study looks at how our body's immune system quickly reacts to bacterial infections and how past experiences with germs can help us fight off future infections better, all by checking how our genes work during the early stages of this response.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project ID | NIH-10643912 on NIH RePORTER |
What this research studies
This research investigates the innate immune response to bacterial infections, focusing on how quickly and effectively the body converts the detection of bacteria into defense mechanisms. It examines the regulation of thousands of genes during the early stages of this immune response and how these genes are translated into functional proteins. By studying the dynamics of translation initiation, the research aims to understand how previous exposures to microbes can enhance future immune responses, potentially leading to better resistance against infections.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals with a history of recurrent bacterial infections or those interested in understanding their immune response better.
Not a fit: Patients with non-bacterial infections or those who do not have an innate immune response may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and preventive strategies for bacterial infections by enhancing our understanding of immune memory.
How similar studies have performed: Previous research has shown promising results in understanding immune responses and translation dynamics, suggesting that this approach could yield valuable insights.
Where this research is happening
Nashville, UNITED STATES
- Vanderbilt University — Nashville, United States (Active)
Researchers
- Principal investigator: Tate, Ann Thomas — Vanderbilt University
- Study coordinator: Tate, Ann Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.